Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 25, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 27, 2026
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001612571-26-000011
Filed / recorded
Aug 27, 2026, 9:09 PM UTC
Added to OQRO
Oct 2, 2026, 12:26 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ABBOTT LABORATORIES
Issuer CIK
1800
Ticker
ABT
Reporting person
Robert B Ford
Relationship
Director, Officer
Officer title
CHAIRMAN AND CEO
Security
Option (right to buy)
Table
Derivative (Table II)
Transaction date
Aug 25, 2026
Transaction code
M
Shares / units
246,963
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.